The influence of sphingosine-1-phosphate receptor signaling on lymphocyte trafficking: How a bioactive lipid mediator grew up from an "immature" vascular maturation factor to a "mature" mediator of lymphocyte behavior and function

Immunologic Research

Volumn 43, Issue 1-3, 2009, Pages 187-197

  Davis, Michael D ^a   Kehrl, John H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Lymphocyte; S1P; Sphingosine 1 phosphate; Trafficking

Indexed keywords

CHEMOATTRACTANT; FINGOLIMOD; LYSOPHOSPHOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

B LYMPHOCYTE; BLOOD VESSEL PERMEABILITY; CELL COMMUNICATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHEMOTAXIS; GENE DELETION; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTOPENIA; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VASCULARIZATION; ANIMAL; CELL MOTION; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM; IMMUNOLOGY; LYMPH NODE; METABOLISM;

ANIMALS; B-LYMPHOCYTES; CELL MOVEMENT; ENDOTHELIUM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPH NODES; PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE; T-LYMPHOCYTES;

EID: 66549097485     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-008-8066-5     Document Type: Review

References (110)

1. Y Liu, et al. 2000 Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation J Clin Invest 106 951 61 11032855 1:CAS:528:DC%2BD3cXnsVeisbw%3D
2. VE Nava JP Hobson S Murthy S Milstien S Spiegel 2002 Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells Exp Cell Res 281 115 27 12441135 1:CAS:528:DC%2BD38XosFOgurs%3D
3. H Liu, et al. 2000 Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform J Biol Chem 275 19513 20 10751414 1:CAS:528:DC%2BD3cXkslahsLs%3D
4. L Yang Y Yatomi Y Miura K Satoh Y Ozaki 1999 Metabolism and functional effects of sphingolipids in blood cells Br J Haematol 107 282 93 10583213 1:CAS:528:DyaK1MXnvFCjtr0%3D
5. P Hanel P Andreani MH Graler 2007 Erythrocytes store and release sphingosine 1-phosphate in blood Faseb J 21 1202 9 17215483
6. K Ito, et al. 2007 Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes Biochem Biophys Res Commun 357 212 7 17418101 1:CAS:528: DC%2BD2sXksFeisbs%3D
7. A Kihara Y Igarashi 2008 Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720 Biochim Biophys Acta 1781 9 496 502 18555808 1:CAS:528:DC%2BD1cXhtVKjtbvO
8. R Pappu, et al. 2007 Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate Science 316 295 8 17363629 1:CAS:528:DC%2BD2sXktVeku70%3D
9. C Pilquil, et al. 2001 Co-ordinate regulation of growth factor receptors and lipid phosphate phosphatase-1 controls cell activation by exogenous lysophosphatidate Biochem Soc Trans 29 825 30 11709082 1:CAS:528: DC%2BD3MXpt1Crtr4%3D
10. H Le Stunff, et al. 2004 Role of sphingosine-1-phosphate phosphatase 1 in epidermal growth factor-induced chemotaxis J Biol Chem 279 34290 7 15180992
11. C Ogawa A Kihara M Gokoh Y Igarashi 2003 Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2 J Biol Chem 278 1268 72 12411432 1:CAS:528:DC%2BD3sXnvVWg
12. H Le Stunff I Galve-Roperh C Peterson S Milstien S Spiegel 2002 Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis J Cell Biol 158 1039 49 12235122
13. J Zhou JD Saba 1998 Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast Biochem Biophys Res Commun 242 502 7 9464245 1:CAS:528:DyaK1cXot1amtg%3D%3D
14. JD Saba F Nara A Bielawska S Garrett YA Hannun 1997 The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase J Biol Chem 272 26087 90 9334171 1:CAS:528:DyaK2sXmvV2jtbg%3D
15. KA Goodemote ME Mattie A Berger S Spiegel 1995 Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate J Biol Chem 270 10272 7 7730331 1:CAS:528:DyaK2MXltlWntr4%3D
16. J Wu S Spiegel TW Sturgill 1995 Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism J Biol Chem 270 11484 8 7744787 1:CAS:528:DyaK2MXls1eisL8%3D
17. T Hla T Maciag 1990 An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors J Biol Chem 265 9308 13 2160972 1:CAS:528: DyaK3cXlvVykurc%3D
18. S An EJ Goetzl H Lee 1998 Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate J Cell Biochem Suppl 30-31 147 57 9893266
19. GC Zondag FR Postma IV Etten I Verlaan WH Moolenaar 1998 Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1 Biochem J 330 Pt 2 605 9 9480864 1:CAS:528:DyaK1cXit1Kns7c%3D
20. O Cuvillier, et al. 1996 Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate Nature 381 800 3 8657285 1:CAS:528: DyaK28XjvVKnsro%3D
21. JP Hobson, et al. 2001 Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility Science 291 1800 3 11230698 1:CAS:528: DC%2BD3MXhslSqsLk%3D
22. JH Paik S Chae MJ Lee S Thangada T Hla 2001 Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins J Biol Chem 276 11830 7 11150298 1:CAS:528: DC%2BD3MXjtFylsLo%3D
23. H Zhang, et al. 1991 Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation J Cell Biol 114 155 67 2050740 1:CAS:528: DyaK3MXksVKku7c%3D
24. S Mandala, et al. 2002 Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists Science 296 346 9 11923495 1:CAS:528:DC%2BD38XjtVWhsrc%3D
25. JH Xie, et al. 2003 Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells J Immunol 170 3662 70 12646631 1:CAS:528:DC%2BD3sXitFKltL4%3D
26. ML Allende, et al. 2004 Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720 J Biol Chem 279 52487 92 15459201 1:CAS:528:DC%2BD2cXhtVCkurzF
27. M Matloubian, et al. 2004 Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 Nature 427 355 60 14737169 1:CAS:528:DC%2BD2cXltFCguw%3D%3D
28. MG Sanna, et al. 2004 Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate J Biol Chem 279 13839 48 14732717 1:CAS:528:DC%2BD2cXis1elsb8%3D
29. C Halin, et al. 2005 The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches Blood 106 1314 22 15870184 1:CAS:528:DC%2BD2MXosVejtrY%3D
30. Y Kharel, et al. 2005 Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720 J Biol Chem 280 36865 72 16093248 1:CAS:528:DC%2BD2MXhtFKhtLzO
31. MA Morris, et al. 2005 Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720 Eur J Immunol 35 3570 80 16285007 1:CAS:528:DC%2BD28XpsVCg
32. J Kunisawa, et al. 2007 Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium J Exp Med 204 2335 48 17875673 1:CAS:528:DC%2BD2sXhtFCntrnL
33. B Balatoni, et al. 2007 FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis Brain Res Bull 74 307 16 17845905 1:CAS:528:DC%2BD2sXhtVWhs7jL
34. Foster CA, et al. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol. 2008; in press.
35. V Brinkmann JG Cyster T Hla 2004 FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function Am J Transplant 4 1019 25 15196057 1:CAS:528:DC%2BD2cXmtFGksLw%3D
36. M Forrest, et al. 2004 Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes J Pharmacol Exp Ther 309 758 68 14747617 1:CAS:528:DC%2BD2cXjs1ygsrg%3D
37. J Zhang, et al. 2007 Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia Am J Physiol Heart Circ Physiol 293 H3150 8 17766476 1:CAS:528:DC%2BD2sXhtlGhsb7J
38. C Xin, et al. 2004 Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses J Biol Chem 279 35255 62 15192102 1:CAS:528:DC%2BD2cXmsl2iurw%3D
39. AM Whetzel, et al. 2006 Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor Circ Res 99 731 9 16960101 1:CAS:528:DC%2BD28XpvFert70%3D
40. DT Bolick, et al. 2005 Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice Arterioscler Thromb Vasc Biol 25 976 81 15761190 1:CAS:528:DC%2BD2MXjsVCjtLY%3D
41. T Fujita, et al. 1994 Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite J Antibiot (Tokyo) 47 208 15 1:CAS:528:DyaK2cXitFaiu78%3D
42. V Brinkmann DD Pinschewer L Feng S Chen 2001 FTY720: altered lymphocyte traffic results in allograft protection Transplantation 72 764 9 11571432 1:CAS:528:DC%2BD3MXns1Kjtb8%3D
43. V Brinkmann, et al. 2001 FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression Transplant Proc 33 530 1 11266942 1:CAS:528:DC%2BD3MXitV2htbk%3D
44. Z Zhang ZY Zhang U Fauser HJ Schluesener 2008 FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves Exp Neurol 210 681 90 18261728 1:CAS:528:DC%2BD1cXksVKrsLg%3D
45. CA Foster, et al. 2007 Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis J Pharmacol Exp Ther 323 469 75 17682127 1:CAS:528: DC%2BD2sXht1ynsLfP
46. T Kohno, et al. 2005 A novel immunomodulator, FTY720, prevents development of experimental autoimmune myasthenia gravis in C57BL/6 mice Biol Pharm Bull 28 736 9 15802820 1:CAS:528:DC%2BD2MXksFagsL0%3D
47. DD Pinschewer, et al. 2000 FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory J Immunol 164 5761 70 10820254 1:CAS:528:DC%2BD3cXjslemtrc%3D
48. Q Liu, et al. 2008 FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma Blood 111 275 84 17761520 1:CAS:528:DC%2BD1cXjtVKhug%3D%3D
49. CP Kaudel, et al. 2007 FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia; impact on long-term survival and T-lymphocyte tissue infiltration Transplant Proc 39 499 502 17362767 1:CAS:528:DC%2BD2sXjtFGnsrs%3D
50. CP Kaudel, et al. 2007 FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model Transplant Proc 39 493 8 17362766 1:CAS:528:DC%2BD2sXjtFGnsr0%3D
51. G Schmid, et al. 2007 The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1 J Cell Biochem 101 259 70 17203465 1:CAS:528:DC%2BD2sXkvFersr8%3D
52. FR Silva LB Silva PM Cury EA Burdmann V Bueno 2006 FTY720 in combination with cyclosporine-an analysis of skin allograft survival and renal function Int Immunopharmacol 6 1911 8 17161344 1:CAS:528:DC%2BD28Xht12ktr7M
53. S Pan, et al. 2006 A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model Chem Biol 13 1227 34 17114004 1:CAS:528:DC%2BD28Xht1Cis7fO
54. Y Deguchi, et al. 2006 The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice Oncol Rep 16 699 703 16969482 1:CAS:528:DC%2BD28XhtFSisrzO
55. GM Meno-Tetang, et al. 2006 Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1, 3-diol hydrochloride) in rats after oral and intravenous doses Drug Metab Dispos 34 1480 7 16751263 1:CAS:528:DC%2BD28Xpt1Sks7o%3D
56. K Man, et al. 2006 Fat-derived hormone adiponectin combined with FTY720 significantly improves small-for-size fatty liver graft survival Am J Transplant 6 467 76 16468955 1:CAS:528:DC%2BD28Xit12gtrg%3D
57. P Troncoso AM Ortiz J Dominguez BD Kahan 2005 Use of FTY 720 and ICAM-1 antisense oligonucleotides for attenuating chronic renal damage secondary to ischemia-reperfusion injury Transplant Proc 37 4284 8 16387098 1:CAS:528:DC%2BD28XktlCm
58. G Penuelas-Rivas, et al. 2005 FTY720 inhibits TH1-mediated allogeneic humoral immune response Transplant Proc 37 4124 6 16386642 1:CAS:528: DC%2BD28XksVKn
59. JY Kim, et al. 2005 Effect of FTY720 on chronic cyclosporine nephropathy in rats Transplantation 80 1323 30 16314802 1:CAS:528:DC%2BD2MXht1Gru7nF
60. H Ueda, et al. 2005 Preoperative administration of FTY720 prolonged renal allograft survival Transpl Immunol 14 1 8 15814275 1:CAS:528: DC%2BD2MXjtlSrt7o%3D
61. S Yan, et al. 2005 Control of intestinal allograft rejection by FTY720 and costimulation blockade Transplant Proc 37 114 5 15808565 1:CAS:528:DC%2BD2MXivFShtbo%3D
62. K Sedlakova E Muckersie M Robertson M Filipec JV Forrester 2005 FTY720 in corneal concordant xenotransplantation Transplantation 79 297 303 15699759 1:CAS:528:DC%2BD2MXhtV2ktrs%3D
63. T Sakagawa H Kiyochi K Honda N Kobayashi 2004 Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation Transpl Immunol 13 161 8 15381198 1:CAS:528:DC%2BD2cXnslCqt7s%3D
64. K Mayer, et al. 2004 FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations Br J Ophthalmol 88 915 9 15205237 1:STN:280:DC%2BD2czgt1aqug%3D%3D
65. M Wijkstrom, et al. 2004 Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720 Transplantation 77 827 35 15077021 1:CAS:528:DC%2BD2cXjs1Cmur8%3D
66. K Budde, et al. 2006 FTY720 (fingolimod) in renal transplantation Clin Transplant 20 Suppl 17 17 24 17100697
67. CP Kaudel, et al. 2006 FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia in C57/BL6 mice Transplant Proc 38 679 81 16647442 1:CAS:528:DC%2BD28XjvFWgs74%3D
68. LM Vaessen NM van Besouw WM Mol JN Ijzermans W Weimar 2006 FTY720 treatment of kidney transplant patients: a differential effect on B cells, naive T cells, memory T cells and NK cells Transpl Immunol 15 281 8 16635750 1:CAS:528:DC%2BD28XjvFWnurc%3D
69. A Skerjanec, et al. 2005 FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship J Clin Pharmacol 45 1268 78 16239360 1:CAS:528:DC%2BD2MXht1aht7%2FO
70. M Suleiman PM Cury JO Pestana EA Burdmann V Bueno 2005 FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury Transplant Proc 37 373 4 15808648 1:CAS:528:DC%2BD2MXivFSntr8%3D
71. VR Galvao M Ginoza M Franco EA Burdmann V Bueno 2005 Prolonged administration of FTY720 does not cause renal toxicity in mice Transplant Proc 37 112 3 15808564 1:CAS:528:DC%2BD2MXivFShtbw%3D
72. K Chiba, et al. 2005 Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate Transplant Proc 37 102 6 15808561 1:CAS:528:DC%2BD2MXivFShtLs%3D
73. Y Shi, et al. 2005 A novel immunosuppressant FTY720 ameliorates proteinuria and alterations of intrarenal adrenomedullin in rats with autoimmune glomerulonephritis Regul Pept 127 233 8 15680492 1:CAS:528: DC%2BD2MXosVGltw%3D%3D
74. T Suzuki, et al. 2004 A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments Transpl Int 17 574 84 15592714 1:CAS:528:DC%2BD2cXhtVGgtLrE
75. M Wang, et al. 2004 Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration Kidney Int 66 1248 56 15327424 1:CAS:528:DC%2BD2cXnvVCrtbc%3D
76. T Bohler, et al. 2004 FTY720 mediates apoptosis-independent lymphopenia in human renal allograft recipients: different effects on CD62L+ and CCR5+ T lymphocytes Transplantation 77 1424 32 15167602
77. D Dragun, et al. 2004 FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury Kidney Int 65 1076 83 14871428 1:CAS:528:DC%2BD2cXitleksbg%3D
78. BD Kahan, et al. 2003 Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study Transplantation 76 1079 84 14557756 1:CAS:528:DC%2BD3sXotFWnsb4%3D
79. L Zhang, et al. 2003 Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft Transplant Proc 35 567 8 12591534 1:CAS:528:DC%2BD3sXht1Krs70%3D
80. HJ Schuurman, et al. 2002 Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD Transplantation 74 951 60 12394836 1:CAS:528: DC%2BD38XotFKrsrg%3D
81. T Boehler M Schuetz K Budde H Neumayer J Waiser 2002 FTY720 alters the composition of T-lymphocyte subpopulations in the peripheral blood compartment of renal transplant patients Transplant Proc 34 2242 3 12270383 1:CAS:528:DC%2BD38Xnt1GgsrY%3D
82. V Brinkmann, et al. 2002 The immune modulator FTY720 targets sphingosine 1-phosphate receptors J Biol Chem 277 21453 7 11967257 1:CAS:528: DC%2BD38Xkslyqtb4%3D
83. K Budde, et al. 2002 First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients J Am Soc Nephrol 13 1073 83 11912269 1:CAS:528:DC%2BD38XjtFSntbw%3D
84. BD Kahan 2002 Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus Ther Drug Monit 24 47 52 11805722 1:CAS:528: DC%2BD38XhsVOit7c%3D
85. V Quesniaux K Menninger M Audet L Gaschen HJ Schuurman 2001 FTY-720 is efficacious in monkey kidney transplantation Transplant Proc 33 2374 5 11377564 1:CAS:528:DC%2BD3MXjslCjtLg%3D
86. P Troncoso M Ortiz L Martinez BD Kahan 2001 FTY 720 prevents ischemic reperfusion damage in rat kidneys Transplant Proc 33 857 9 11267102 1:CAS:528:DC%2BD3MXitV2gur4%3D
87. T Bohler, et al. 2000 FTY 720A mediates reduction of lymphocyte counts in human renal allograft recipients by an apoptosis-independent mechanism Transpl Int 13 Suppl 1 S311 3 11112021
88. T Omura, et al. 1999 A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation Transplant Proc 31 2783 4 10578289 1:CAS:528:DyaK1MXntlektr4%3D
89. P Troncoso, et al. 1999 Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine Transplantation 67 145 51 9921811 1:CAS:528:DyaK1MXhtVeqtbs%3D
90. K Yuzawa, et al. 1998 An effect of FTY720 on acute rejection in canine renal transplantation Transplant Proc 30 1046 9636422 1:CAS:528: DyaK1cXktF2gsbw%3D
91. S Suzuki, et al. 1998 An immunosuppressive regimen using FTY720 combined with cyclosporin in canine kidney transplantation Transpl Int 11 95 101 9561675 1:CAS:528:DyaK1cXjtFeksb8%3D
92. S Suzuki, et al. 1996 A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation Transplantation 61 200 5 8600623 1:CAS:528: DyaK28XhsV2msLo%3D
93. V Brinkmann D Pinschewer K Chiba L Feng 2000 FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation Trends Pharmacol Sci 21 49 52 10664606 1:CAS:528:DC%2BD3cXht1Krs7g%3D
94. G Henning, et al. 2001 CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720 J Exp Med 194 1875 81 11748287 1:CAS:528:DC%2BD38Xpt1aq
95. B Zemann, et al. 2006 Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720 Blood 107 1454 8 16223773 1:CAS:528:DC%2BD28XhsFemtrw%3D
96. SW Paugh SG Payne SE Barbour S Milstien S Spiegel 2003 The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2 FEBS Lett 554 189 93 14596938 1:CAS:528:DC%2BD3sXosVyls7o%3D
97. I Ishii, et al. 2002 Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3 J Biol Chem 277 25152 9 12006579 1:CAS:528:DC%2BD38XlsVWiur4%3D
98. AJ MacLennan, et al. 2001 An essential role for the H218/AGR16/Edg-5/ LP(B2) sphingosine 1-phosphate receptor in neuronal excitability Eur J Neurosci 14 203 9 11553273 1:STN:280:DC%2BD3MrhtVGrsg%3D%3D
99. I Ishii, et al. 2001 Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3 J Biol Chem 276 33697 704 11443127 1:CAS:528: DC%2BD3MXmslylsbo%3D
100. JN Lorenz LJ Arend R Robitz RJ Paul AJ MacLennan 2007 Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice Am J Physiol Regul Integr Comp Physiol 292 R440 6 16990495 1:CAS:528:DC%2BD2sXisFGhsrs%3D
101. AJ MacLennan, et al. 2006 The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function Hear Res 220 38 48 16945494 1:CAS:528:DC%2BD28XptlyqsLY%3D
102. MG Sanna, et al. 2006 Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo Nat Chem Biol 2 434 41 16829954 1:CAS:528:DC%2BD28XmvFyqsrw%3D
103. FW Foss Jr, et al. 2007 Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists Bioorg Med Chem 15 663 77 17113298 1:CAS:528:DC%2BD28XhtleisL%2FP
104. G Cinamon, et al. 2004 Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone Nat Immunol 5 713 20 15184895 1:CAS:528:DC%2BD2cXlt1Wmurk%3D
105. KA Vora, et al. 2005 Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement J Leukoc Biol 78 471 80 15894589 1:CAS:528:DC%2BD2MXntFCjsLg%3D
106. J Kunisawa, et al. 2008 Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells Blood 111 4646 52 18292290 1:CAS:528:DC%2BD1cXlsVSrs70%3D
107. J Kunisawa, et al. 2007 Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production Blood 109 3749 56 17234743 1:CAS:528:DC%2BD2sXkvFCit7Y%3D
108. II Singer, et al. 2005 Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes J Immunol 175 7151 61 16301618 1:CAS:528:DC%2BD2MXht1entrbK
109. SH Wei, et al. 2005 Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses Nat Immunol 6 1228 35 16273098 1:CAS:528:DC%2BD2MXhtlShur3E
110. LG Ledgerwood, et al. 2008 The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics Nat Immunol 9 42 53 18037890 1:CAS:528:DC%2BD2sXhsVegtLnN